FIELD: medicine, veterinary science, virology. SUBSTANCE: method involves intramuscular or intranasal administration of reaferon and/or ridostin, and/or polyribonate before or at period of possible infection. EFFECT: enhanced effectiveness of viral aerogenic infections prophylaxis. 4 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF INHIBITING INFECTIOUS ACTIVITY OF EBOLA VIRUS IN EXPERIMENT | 2015 |
|
RU2585695C1 |
| METHOD OF PREPARING SERA CONTAINING ANTIBODIES RAISED TO MARBURG VIRUS | 1995 |
|
RU2085214C1 |
| ANTIVIRAL AGENT | 1996 |
|
RU2123339C1 |
| PROLONGED-EFFECT INTERFERON INDUCTOR | 1999 |
|
RU2172631C2 |
| STRAIN OF EBOL VIRUS "ZAIR K-5" FOR CARRYING OUT MODEL EXPERIMENTS AND PREPARING DIAGNOSTIC AND VACCINE PREPARATIONS | 2001 |
|
RU2225439C2 |
| METHOD OF PREVENTING DISEASE CAUSED BY AVIAN FLU VIRUS | 2008 |
|
RU2395295C2 |
| METHOD OF IMMUNIZATION AGAINST INFECTION CAUSED BY TICK-BORNE ENCEPHALITIS VIRUS | 1997 |
|
RU2136312C1 |
| LIPOSOMAL ANTIVIRAL DRUG FOR ORAL USING | 1996 |
|
RU2123328C1 |
| EARLY DIAGNOSTIC TECHNIQUE FOR EBOLA HEMORRHAGIC FEVER IN INDIVIDUALS PRESUMABLY INFECTED WITH SUCH VIRUS | 2010 |
|
RU2450274C1 |
| METHOD FOR BODY PROTECTION AGAINST INFECTION CAUSED BY INFLUENZA A VIRUS SUBTYPE H1N1 STRAINS WITH PREPARATION OF HUMAN ALPHA-2 INTERFERON | 2013 |
|
RU2523554C1 |
